Aardvark Therapeutics Inc(AARD) - 2024 Q4 - Annual Results

Exhibit 99.1 Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small- molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today reported financial results for the full year ended December 31, 2024, and provided business highlights. Forward-Lo ...